Acne inversa: research on pathogenesis and preclinical testing of potential therapeutic approaches - PFBC-Exp-02 (Exp02)

Charité Universitätsmedizin Berlin0 个研究点目标入组 1,260 人开始时间: 2022年6月9日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•patients with Acne inversa, other chronic inflammatory skin diseases or healthy participants respectively
•- age: = 18 years
•- blood Hb > 10 g/dl (exept if residual material obtained from excision surgery or diagnostic biopsies is used)
•- willingness to comply with study procedures (taking of skin biopsies)
•- written, informed consent was given

•- age: <18 years,
•- persons, who are not able to give wrtitten informed consent,
•- pregnancy or breast feeding,
•- intake of medication that influences blood ,coagulation the last 10 days before the planned procedures (taking of blood or skin samples),
•- known allergies against local anesthesia, patches or latex/gloves,
•- known acute or chronic infectious diseases (e.g. influenza, HIV, HCV, HBV, Covid-19
•- known malignancies,
•- anamnestic hints to exuberant formation of scars or keloids,
•- person, who are in the physician´s view not able to fulfill the study requirements.

发起方